Lately the old sure bets in Magic finance have seemed less and less reliable, due to reprints and large format shake-ups. Corbin suggests some ways to hedge to cover your increased risk in the new environment.

Four months after M15, Sylvain’s speculative strategies for the set have panned out wonderfully. With the winter coming up, Sylvain reviews his investments and prepares for what should be the best season for many positions.

Several cards from Khans have made quite the impact on Eternal formats, and now may seem a tempting time to scoop up foils. Jason Alt breaks down the reasons he thinks these cards are more than likely on the downswing.

Foil cards present a great opportunity to protect and grow your Magic investments. But how do you choose?

Star City Games recently made two statements that could impact every competitive format of Magic. But what do these changes mean for prices? This week Sigmund shares his outlook for every format and shares where he’s focusing his hard-earned cash.

David Schumann runs down the Stock Watch for this week, covering the biggest movers in the categories of Penny, Blue Chip, Value and Growth Stocks.

The real cost to acquire a deck shifts if you can assume you’ll resell the cards later. Danny Brown applies his analysis of deck costs to Modern, and shows off some of Traders Tools features in the process.

Many boogeymen were said to have been introduced into Modern by way of Khans, but do the latest results bear that out? Corbin investigates the newest developments evidenced by the Grand Prix results.

Adam retells the many storylines of Grand Prix New Jersey. He also shares the top-performing decklists, reveals the secrets they hold, and explains their metagame position moving forward.

Sylvain goes deeper in explaining his thought process when pulling the trigger to sell. Responding to insiders’ comments, he explains why early sales have done more good than bad for him.

Popularity with the Commander crowd can certainly affect a card’s price, but not all Commander staples are created equal. Jason Alt looks at some key cards and explains which factors are the real determinants.

This week Derek prognosticates Magic’s final days.

At first glance, the turnout at GP New Jersey indicates the health of Legacy. But is there more than meets the eye? This week Sigmund examines pricing trends to make his own assessment, which may be gloomier than expected.